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Medicinal plantAbstract Nigella sativa (NS) or black cumin is a dark, thin, and crescent-shaped, seeded shrub
belonging to the Ranunculaceae family commonly growing on Mediterranean coasts in Saudi
Arabia, northern Africa and Asia. They have amazing curative and therapeutic features that make
them one of the most popular, safe, non-detrimental, and cytoprotective medicinal plant that can be
used for prevention and treatment of many complicated diseases. Originally, N. sativa was used to
treat migraines and allergy, and researches have shown its effectiveness in destroying cancer cells as
well. The gastro protective effect of NS oil and its constituents has also been reported earlier;
however, the complete perception on etiology and pathogenesis of gastric ulcer is not yet clear.
Herein, we attempt to unveil some of the potential mechanisms exhibited by NS in preventing
problems related to gastric ulcers. Gastric ailments like ulcers and tumors are the most common
disorders of the gastro-intestinal tract in the present day life of the industrialized world. Gastric
Gastro-protective role of Nigella 543ulcer being a multifaceted problem exhibits complex etiology and is the fourth most common cause
of cancer mortality. Drug interactions and toxicity are the main hindrances in chemotherapy.
The existing merits and demerits of modern-day drugs make us turn toward the plant kingdom
which may provide a valuable resource of novel potent natural compounds for pharmaceuticals
or alternately, as dietary supplements. In this context, the revered phytotherapeutic N. sativa comes
as a promising savior in today’s times. This review aims to summarize, both the functional and
disease-related effects in the area of gastroenterology.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Nigella sativa (NS), a medicinal and nutritional plant, became
the focus of interest amongmodern day researchers fromChem-
istry, Biology, Agriculture, Pharmacology andMedical Sciences
since 1970s. However, the Ayurvedic, Unani and Herbal Medi-
cine practitioners were extensively using NS since hundreds of
years for ailments ranging from a simple headache to disorders
like diabetes, hypertension, gastrointestinal problems, menstru-
ation and lactation (Al-Rowais, 2002; Salem, 2005).
NS, a member of Ranunculaceae family growing on the
Mediterranean coasts, is a short 8–12 inch high annual herb,
with pinnate segmented leaves. The blue and white ﬂowers
are solitary, self pollinating and form a fruit capsule consisting
of trigonal seeds. Presently, these seeds due to its pepper oreg-
ano like taste are generally used as a seasoning in cuisines
world over. Additionally they have signiﬁcant medicinal bene-
ﬁts, making it one of the most cherished medicinal spices
(Fallah Huseini et al., 2011). Arabs considered it as ‘Habbatul
Barakah’ or the blessed seed (Al-Rowais, 2002). Metabolites of
N. sativa seeds possess myriad of potent therapeutic features
for the immune, cardiovascular, respiratory, gastric and
endocrinal health (Ahmad et al., 2013; Gilani et al., 2001).
The black cumin seeds contain more than 100 chemical com-
pounds, a number of them are yet to be characterized. The
phyto-components of NS seeds include nigellone, thymoqui-
none, phytosterols, fatty acids, vitamins, and minerals
(Boseila and Messalam, 2011). The composition and yield of
its essential oils differ depending upon geographical conditions
as well as the varied hydrodistillation methods employed for
oil extraction. Primary components of the essential oil are
monoterpenes (87.7%) like p-cymene, carvacrol, a-thujene, c-
terpinene, a-pinene and b-pinene and its oxygenated deriva-
tives (9.9%), rest being sesquiterpenes and derivatives (Wajs
et al., 2008).
Gastric ulcer, one of the most prevalent ailments, is due to
an imbalance between the aggressive and defensive mecha-
nisms (Alkofahi and Atta, 1999). The gastric mucosa is con-
stantly exposed to harmful agents such as drugs, pepsin,
gastric acid, bile acids, microbial antigens like Helicobacter
pylori (H. pylori), Epstein Barr virus and food ingredients
(Peskar and Maricic, 1998). These causative factors have been
associated with the pathogenesis of gastric ulcerations by
means of pronounced gastric acidity, increased inﬂammatory
markers and cell proliferation along with reduced gastric
motility and gastric blood ﬂow (Toma et al., 2005). Gastric
irritants like ethanol are also known to induce contraction of
the fundic strip circular muscles in rats, causing musculo-com-
pression. Such a stress at the mucosal fold crests progresses
toward ulceration and necrotic effects (Abdulla et al., 2010).Treatment of peptic ulcers either counteracts aggressive factors
like pepsin, acid, active oxidants, leukotrienes, platelet aggra-
vating factor, endothelins, bile and exogenous factors includ-
ing non-steroidal anti-inﬂammatory drugs (NSAIDs) or
stimulates the mucosal defenses like normal blood circulation
and production of mucus, prostaglandins (PGs), nitric oxide
and bicarbonate (Borrelli and Izzo, 2000). An imbalance of
harmful and protective factors leads to gastric ulcers. Stress
is a prime factor in the pathogenesis of gastric ulcers, wherein
neutrophil inﬁltration (Abdallah et al., 2009), pepsin (Kotani
et al., 2007), secretion of gastric acid (Tanaka et al., 2002)
and formation of lipid peroxidation products, nitric oxide
and redox imbalance (El-Abhar et al., 2003) are the main
parameters implicated. The gastric lesions produced are healed
by antioxidants (Yoshikawa et al., 1991, 1989), proton pump
inhibitors and drugs lowering gastric secretion (Kitano et al.,
2006). Treating peptic ulcer involves relief from pain and acid-
ity, ulcer healing and recurrence prevention. Currently, no eco-
nomically feasible treatment meeting all these goals exists.
Many over the counter drugs, claiming to give relief are intro-
duced overnight and then also hurriedly withdrawn on ﬁndings
of serious side effects. Under these circumstances a tried and
tested remedy over centuries can be far more safely relied
upon. Hence, majority of the people around the globe rely
on natural remedies. Spices such as NS, oregano, black pepper,
fennel, clove, cinnamon, fenugreek, turmeric, and ginger con-
tain potential anti-oxidative phytoconstituents (Adhikari
et al., 2007). Herbs like galanga, pepper, cloves, turmeric,
and cardamom have been favorably researched for their anti-
ulcer effects (Al-Moﬂeh et al., 2006; Al-Moﬂehi et al., 2005;
Al-Yahya et al., 1990; Al Moﬂeh et al., 2008; Alhaider et al.,
2005a,b; Rafatullah et al., 1995, 1990).
Due to limitation of scientiﬁc investigation and resource
dependency, socio-economic factors, religious faith, and ances-
tral experience, locally available spices and herbal medicine
were considered as a central part of traditional complementary
medicine. However, effective practice and result oriented usage
over a long period of time have established the efﬁcacy of
many cheap and easily available speciﬁc ﬂora for the treatment
of various ailments. Spices contain anticancer potential in
addition to their anti-ulcerogenic activity which is likely due
to the anti oxidative action of their different phytoconstituents
(Mothana et al., 2009; Shan et al., 2005). The antioxidant and
scavenging ability of reactive oxygen species (ROS) intercedes
gastro-protection.
This review aims to elaborate our present pharmacological
and toxicological knowledge of the actions of this plant
in speciﬁc context to gastric ulcers. We hope to produce a
clinical appraisal and evaluation of its efﬁcacy in the treatment
of gastric ailments, due to the different properties exhibited by
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uments the complementary scientiﬁc knowledge for later gen-
erations who may have not known the beneﬁts of the long
standing usage and practice of natural remedies. It also cor-
rects the misunderstanding of such people who are misled by
the pharmaceutical trade and medicine in declining the usage
of NS on account of lack of scientiﬁc validation in gastric
pathophysiology.
2. Chemical constituents of N. sativa
NS oil is dark yellowish in color containing thymoquinone,
carvone, D-limonene, melanthin, tannins, p-cymene, a-pinene,
thymol, dithymoquinone, thymohydroquinone and alkaloids
(nigelline-N-oxide, nigellone, and nigellimine). The oil content
of NS seeds ranges from 0.1% to 1.5%, depending on extrac-
tion method and distillation duration. A high quantity of
unsaturated fatty acids (74.4–82.5%), comprising arachidonic,
eicosadienoic, oleic, linoleic and linolenic acid and a lesser
extent of saturated fatty acids (14.9–17.3%) were noted in its
oil as well (Al-Jassir, 1992; Boseila and Messalam, 2011).
The constituents of the black seed, nigellone, thymoquinone
and numerous unsaturated fatty acid esters with terpene alco-
hols, make it an immune system booster. However, toxic prop-
erty of melanthin in large doses and paralytic effect of nigelline
have been alerted to be used in moderation.
3. N. sativa: a potential medicinal candidate for various ailments
NS is one of the most promising curative herbs with a lot of
folklore, and traditional therapeutic applications worldwide
and more so in the Arab world (Al-Rowais, 2002) (Fig. 1). It
has been known to retard the progression of many chronic dis-
eases (Ragheb et al., 2009). NS seeds and oil extract have been
known to be positively implicated in allergy, diabetes, cardio-
vascular problems like hypertension and hyperlipidemia, gas-
tro-intestinal problems, inﬂammatory and oxidative damage
processes. Its antihistaminic, antioxidative and immunomodu-
lator properties cover a wide range of degenerative health
problems (Fallah Huseini et al., 2011) apart from few recent
reports of its anti-viral properties against HIV and HepatitisFigure 1 Medicinal importance and poC (Barakat et al., 2013; Onifade et al., 2013). Low toxicity
and antioxidant properties of NS leading to free radical
quenching make it a potential candidate drug for inﬂamma-
tory as well as stress related disorders (Bylka, 2009; Hasani-
Ranjbar et al., 2009). The natural antioxidant potential of this
seed is evident by the phenols, phospholipids, phytosterols and
tocopherols present in them. Radical scavenging activity of the
oil fractions toward stable galvinoxyl and 1,1-diphenyl-2-pic-
rylhydrazyl radical showed that the phospholipids possess
greater free radical scavenging activity as compared to
glycolipids and neutral lipids (Ramadan et al., 2003). NS is
an extremely potential herbal source for the development of
pharmaceutical products and drugs against a number of
pathological conditions relating to oxidative damage. Though
thymoquinone is the main bioactive compound of NS, other
compounds like alkaloids, phytosterols, ﬂavonoids, carotene,
and saponins do contribute their bit toward the immense
beneﬁts this seed possesses.
Mechanisms involved in the damage and repair of the gas-
tro-intestinal tract could help to develop new therapeutic
approaches to the problems envisaged. Experiments conducted
by Sabikhi et al. suggest that oils rich in a-linolenic acid and c-
linolenic acid exhibit both antisecretory and anti-ulcerogenic
properties (Sabikhi and Sathish Kumar, 2012). Gastric lesions
seem to be reduced and gastric microcirculation increased,
showing that the bioactivity of NS stretches from its antioxi-
dant property to being anti-ulcerative and cytoprotective
(Zayachkivska et al., 2004). Cancer cell development, growth
and proliferation are important aspects in carcinogenesis.
Cell cycle regulatory protein expression, and/or activity seem
to be affected by NS leading to apoptosis, and DNA damage
(Gali-Muhtasib et al., 2004).
Effective healing, protection and repair of gastric damage
with the use of NS probably are due to its antioxidant, antihis-
taminic and antiperoxidative actions (Kanter et al., 2006) (see
Table 1). We have listed numerous pharmacological properties
of NS applicable to various diseases; however this article will
focus on its potential effects on gastric acidity, and properties
of its ingredients as anti-microbial, anti-inﬂammatory, anti-
oxidant, anti-histaminic, immunopharmacological and immu-
nomodulatory aspects in gastric ulcers/cancer.tential applications of Nigella sativa.
Table 1 Protective effects of the active constituents of Nigella on gastric pathophysiology.
Active constituent References Proposed mechanism of action
Thymoquinone (30–48%) Ahmad et al. (2013) Cytoprotection, hydroxyl radical
scavenging activity, inhibition of LPO,
anti-inﬂammatory, immune boosting,
digestive and carminative
Carvacrol, carvone, D-limonene, melanthin, tannins,
p-cymene, a-pinene, thymol, dithymoquinone and
thymohydroquinone
Ahmad et al. (2013) Hydroxyl radical scavenging activity
Alkaloids: nigelline-N-oxide, nigellone, nigellimine Ahmad et al. (2013) Anti-histamine
Saponin, triterpene-alpha-hederin Ahmad et al. (2013) Anticancer and anti-leishmanial
property
Total fat (28.5%)
Fatty acids: saturated (30%)-myristic acid, palmitic
acid, stearic acid
Unsaturated (70%)-oleic (20–24%), linoleic acid (50 –
60%), linolenic acid (0.83–2.38%), eicosadienoic acid
(3%), arachidonic acid, dihomolinoleic acid (10%)
Ahmad et al. (2013) and
Ramadan and Morsel (2002)
Anti-inﬂammatory, immune boosting,
skin moisture balancer
Flavonoids Badary et al. (2003) and Merfort
et al. (1997)
Superoxide anion scavenging activity
Phenols, vanillic acid (0.143%) Shan et al. (2005) Antioxidant and antimutagenic activity
Phytosterols (1.9–2.8%): a-sitosterol (44–54% of total
sterols), stigmasterol (6.57–20.92% of total sterols)
Ahmad et al. (2013), Heese-Peck
et al. (2002) and Matthaus and
O¨zcan (2011)
Yeast endocytosis
a, b and c-tocopherols (0.009–0.027%) Matthaus and O¨zcan (2011) Antioxidant, immune boosting
Vitamins: carotene, vitamin B1, vitamin B2, vitamin
B3, folic acid
Ahmad et al. (2013) Free radical scavenger and primary
antioxidant, immune boosting
Minerals: calcium, iron, copper, zinc, and
phosphorous (1.79–3.4%)
Bassim Atta (2003) Chelating action, inhibition of free
radical generations by stabilization of
transition metals, thereby reducing free
radical damage
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Gastric acidity is an important indicative factor for gastro-
intestinal damage. Experiments show that the volume of gas-
tric acid produced determines the permeability of the gastric-
mucosal wall which triggers and accelerates the development
of ulcers (Money et al., 1986). Inhibition of acid production
by NS may well maintain the permeability of the gastric muco-
sal membrane and help reduce the formation of gastric ulcers.
Lowering of gastric acidity by NS and increase in the gastric
mucosal content act as a potential defensive factor against
the gastric damage and ulceration (Swarnakar et al., 2005).
Reduced gastric surfaces exhibiting ulcerations, suppression
of edema and inﬁltration of leucocytes on the sub-mucosal
layer have been observed in the NS treated group as compared
to the controls. Pre-treatments with NS have shown to exhibit
a preventive action against gastro-intestinal damage and
ulcerogenic acceleration. Also neutralization of the acid con-
tent in the stomach may well be reasoned enough for speeding
up the healing of gastric ulcers (Abdel-Sater, 2009).
NS exhibits a gastroprotective effect, which might be
because of reduced concentration of acid secretion. The cura-
tive action of thymoquinone on acute gastric damage induced
by ethanol in rats has been shown in studies done by Arslan
et al. (Arslan et al., 2005). Recent results of in vitro experiments
done by Ahmet and colleagues show that dose of 2 mg/100 ml
DMSO and 5 mg/100 ml DMSO of NS aqueous extracts
decreases histamine stimulated gastric acid secretion. A 5 mg/
100 ml DMSO of NS aqueous extract also lessened bethanechol
stimulated gastric acid secretion, but none of the NS dosesseemed to affect pentagastrin-induced acid secretion. Antisecre-
tory studies with NS show noteworthy reduction in acidity,
pepsin content as well as ulcer index (Topal and Celebi,
2011). Up regulation of gastric mucosal secretion is also
observed after NS administration. Gastric mucosal production
which is one of the defensive factors against gastric ulcer forma-
tion is increased by NS (Mahmood et al., 2011; Wasman et al.,
2010), thus making NS a strong anti-ulcerous compound.
3.2. Anti-microbial effects of N. sativa on gastric ulcers
NS seed extract has been shown to possess anti-microbial
activity against Staphylococcus aureus, Escherichia coli, Pro-
teus vulgaris, and Candida albicans. Its essential oils act more
against gram-positive bacteria than the gram-negative ones.
NS essential oil has a higher antibacterial activity compared
to tetracycline, cefuroxime, and ciproﬂoxacin and stronger
antifungal properties in contrast to clotrimazole (Haloci
et al., 2012). The use of natural therapeutic products will prob-
ably not bring forth resistance in microorganisms as compared
to the common menace of antibiotic resistance.
Diseases like peptic ulcer, gastric cancer and chronic gastri-
tis are ascribed to H. pylori. Though antimicrobial agents
could successfully remove H. pylori infection it could also lead
to regression of disorders associated with H. pylori. H. pylori is
increasingly turning antibiotic resistant, making it necessary to
research out novel effective agents. NS possesses in vitro anti-
helicobacter activity comparable to triple therapy (Salem et al.,
2010). The antibacterial activity of the phenolic component of
NS oil was ﬁrst reported by Toppozada in 1965 (Toppozada
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with several antibiotics in vitro. Diethyl-ether extract of NS
inhibits both gram-positive and gram-negative bacteria, as well
as pathogenic yeast (Hanafy and Hatem, 1991) and has a
promising effect on multi-drug resistant organisms (Morsi,
2000). In an in vitro experiment, NS extract produced a
100% growth inhibition of all the H. pylori strains that were
tested within 60 min (O’Mahony et al., 2005). It is therefore
likely that a combination of NS with antibiotics will reduce
the possibility of emergence of resistant H. pylori colonies
thereby improving the antibiotic efﬁcacy.3.3. Anti-inﬂammatory properties
Interventions in pathways of inﬂammation have been known
to possibly delay cancer development and progression thereby
improving patient life quality. Compounds like PGs and leu-
kotrienes (LT) are well known as inﬂammatory mediators
(Brzozowski et al., 2005; Christie and Henderson, 2002). NS
is known to possess approximately 78.4% total unsaturated
fatty acids namely linoleic acid (52.6%), alpha-linolenic acid
(0.83–2.38%), oleic acid (23.5%) and cis-11, 14-eicosadienoic
acid (1.2–3.1%) (Ali et al., 2012; Nickavar et al., 2003). Die-
tary lipids enriched with omega-3 fatty acids, a derivative of
polyunsaturated fatty acids (PUFAs), are known to possess
anti-inﬂammatory properties and increase membrane perme-
ability of the mucosal barrier (Grant et al., 1988). Earlier
researches have also shown the association of PUFAs with
gastric and duodenal ulcers as well as H. pylori growth
(Frieri et al., 1995). Release of PUFAs from the injured
mucous cell membrane has been shown to competitively inhi-
bit the pro-inﬂammatory cytokines and tumor necrosis factor
a (Ciacci et al., 1993). Oral doses of PUFAs have been shown
to exhibit bacteriostatic effects on H. pylori, though higher
doses could prove bactericidal (Knapp and Melly, 1986;
Thompson et al., 1990; Thompson and Spiller, 1995). Dosage
and time period of supplementation of PUFAs could be instru-
mental in exhibiting its activity. Thus the presence of PUFAs
and TQ in NS oils makes it a powerful anti-inﬂammatory com-
pound by inhibiting the synthesis of inﬂammatory cytokines
(Mori and Beilin, 2004; Wallace, 2005) namely leukotrienes
and thromboxanes by inhibiting the lipoxygenase (LOX) and
cyclooxygenase (COX) activities (Houghton et al., 1995). The
inﬂammatory LOX cascade plays a vital role in the gastric
ulcers induced by irritants such as alcohol (Lange et al.,
1985). Production of 5-hydroxy-eicosatetraenaoic and 5-LOX
that are important for the cancer cell viability is inhibited by
NS (El-Dakhakhny et al., 2002). Therefore, inhibition of 5-
LOX enzyme could well be an approach toward apoptosis
(Hoque et al., 2005). Reduced production of leukotrienes by
TQ increases its potential in making NS an important candi-
date in anti-inﬂammation (Padhye et al., 2008).
Restitution of the gastro-intestinal lining has been found to
be inﬂuenced by PUFAs (Ruthig and Meckling-Gill, 1999,
2002). The ﬁxed oil exhibits anti-inﬂammatory properties
greater than a NS active TQ constituent illustrating that syner-
getic property and effects of other phytochemicals, also have a
signiﬁcant role in the anti-inﬂammatory cascade. TQ was
found to signiﬁcantly inhibit production of interleukins IL-5
and IL-13 mRNA expression but not IL-10 production in var-
ious studies (El Gazzar, 2007; El Gazzar et al., 2007). Thenuclear transcription factor kappa B (NF-jB) is now being
looked upon as an important mediator of inﬂammation. Sup-
pression or alteration in the NF-jB dimers, signals the onset of
a pathological condition. Activation of the redox sensitive NF-
jB, stimulates the expression of different enzymes, cytokines
and intermediary compounds related to the inﬂammatory cas-
cade (Sayed and Morcos, 2007). Therefore the proper activa-
tion and expression of NF-jB decide the pathological
condition of a particular disease. Apart from other diseases,
NF-jB pathway is also elemental in inﬂammatory bowel dis-
ease and other inﬂammatory conditions of the gastro-intestinal
system (Aggarwal et al., 2011). TQ also has been shown to
down regulate NF-jB dependant antiapoptotic genes, NF-jB
and the bcl2 family (Rajkapoor et al., 2002). NS exhibiting
potent anti-inﬂammatory properties could well inhibit NF-
jB thereby reducing the chronic inﬂammation and prevents
or delays the onset of chronic health problems (Aggarwal
et al., 2011; Sethi et al., 2008).
3.4. Anti-oxidative properties of N. sativa
Oxidative stress is a key factor in gastric ulcer pathogenesis,
and antioxidants offer gastric mucosal protection against dif-
ferent agents causing necrosis (Pathak et al., 2005; Trivedi
and Rawal, 2001). NSAID’s, bile acids and alcohol reduce
the protective barrier and increase the hydrogen ion H+ back
diffusion and thereby augments susceptibility to ulcers (Al
Moﬂeh, 2010). Several epidemiological studies show a direct
correlation of increased antioxidant intakes with decreased risk
of cancer (Borek, 2004). NS is a powerhouse of antioxidants
and contains compounds aiding the inhibition of gastric secre-
tion. The antioxidant properties in NS not only depend on the
composition of phenolic compounds in the seed variety, but
also other conditions of growth and processing (Skrovankova
et al., 2012). The plant extract of NS exhibits gastro protective
activities by strengthening the mucosal barrier and withstand-
ing endogenous as well as exogenous ulcerogenic agents prob-
ably due to its antioxidant activity (Meral et al., 2001).
Flavonoids present in NS (Merfort et al., 1997) may be respon-
sible for the antiulcerative effects (Zayachkivska et al., 2004,
2005), and thereby offer gastroprotection (La Casa et al.,
2000). Flavonoids in NS stimulate the gastric mucus and help
strengthen the mucosal immune defense system by scavenging
superoxide and hydroxyl free radicals (Badary et al., 2003;
Kruk et al., 2000; Mansour et al., 2002). Various components
in the oil or seed extract have been found to act synergistically
thereby increasing their antioxidant capacity as well as usage in
the pharmaceutical industry (Ali and Blunden, 2003).
Antioxidant status in plasma along with the cellular struc-
ture and function of membrane is restored by effectively reduc-
ing the concentrations of plasma lipid peroxidation markers
like malondialdehyde, conjugated diene, and lipid hydroperox-
ide, thus making thymoquinone (TQ) a potent food additive
against free radical damage. TQ has been shown to inhibit car-
cinogenesis by decreasing lipid peroxidation and increasing the
cellular antioxidant capacity (Badary et al., 2007).
Non-enzymatic inhibition of lipid peroxidation has been
observed with TQ as well as the whole oil (Houghton et al.,
1995). Kanter and colleagues studied the gastro-protective
effect of NS oil in chemically induced gastric ulcers in rats
(Kanter et al., 2003, 2005). 1 ml/kg dose of volatile NS oil
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with ethanol considerably protected the animals. Also signiﬁ-
cant elevation in the gastric glutathione (GSH), superoxidase
dismutase and the glutathione-S-transferase activities along
with major reductions in alcohol-induced lipid peroxidation
in the gastric mucosal cells was observed. Supplementation
studies with NS, resulted in an increase in the antioxidant
GSH levels thereby accelerating the gastric healing process
(Shen, 1979). Even reduced dosages of raw NS at 0.25 g/kg
showed considerable improvement in the ulcer healing. Deple-
tion of GSH, a very potent antioxidant and component for
gastric mucosal protection results in the mucosal damage.
NS oil in low concentrations has been shown to suppress the
formation of lipid peroxide and lactate dehydrogenase and
increase the availability of superoxide dismutase and GSH,
simultaneously decreasing lipid peroxidation and free radical
generation (Houghton et al., 1995; Mansour, 2000; Wada
et al., 1995, 1997). NS has a vital function in electron transfer
and oxygen activation with TQ having the potential to be used
in free radical related disorders. TQ can effectively quench
superoxide anion radical (O2) and hydroxyl radical (HO)
(Kruk et al., 2000). Moreover total antioxidant enzyme levels
can be normalized by modulating the levels of glutathione
reductase, reduced GSH, glutathione-S-transferase, glutathi-
one peroxidase, superoxide dismutase, catalase, and erythro-
cyte membrane-linked ATPases (Ahmad and Beg, 2013).
These gastro-protective effects of NS are observed in the raw
state, but not when the seed or oil is boiled due to possible
alterations in the chemical composition (Bastaki et al., 2011).
Non-enzymatic reactions of GSH with reduced forms of
NADPH and NADH result in the rapid formation of gluta-
thionyl-dihydro-thymoquinone and a slower formation of
dihydro-thymoquinone (DHTQ). The combination of these
two renders them as free radical scavengers possibly more
powerful than TQ itself (Khalife and Lupidi, 2007). Total anti-
oxidant activity of these reduced compounds against 2,2/-azin-
obis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 2,2-
diphenyl-1-picrylhydrazyl (DPPH) showed scavenging effect
of glutathionyl-dihydrothymoquinone quite similar to DHTQ.
TQ on its own exhibited a slightly lesser scavenging potential
(Padhye et al., 2008).
In vitro studies showed DPPH radical inhibition and ferric
reducing capacity values to be 95.89% and 3.33 mmol/L
Trolox, respectively with NS when compared to a few other
essential oils like thyme, fennel and lavender (Viuda-Martos
et al., 2011). The metabolite dihydrothymoquinone formed
from TQ is also responsible for the various beneﬁcial effects
of NS (Mansour et al., 2002). Histological studies corroborate
the beneﬁcial effects by showing that TQ pretreated groups in
the dose of 20 mg/kg helped maintain an intact cellular
structure.
Clinical condition of methionine induced hyper-homocy-
steinemia was corrected by oral feeding of NS oil or TQ which
protects by enhancing the antioxidant status and ameliorating
the triglycerides, lipid peroxide and cholesterol concentration
in plasma. Most recently, the antioxidant properties of the
methanolic crude extract of NS seed cake were also investi-
gated and some of the phenolic compounds such as syringic,
hydroxybenzoic and p-coumaric acids were identiﬁed with
signiﬁcant antioxidant properties under in vitro systems
(Shrivastava et al., 2011).3.5. Anti-histaminic/anti allergic properties of N. sativa
Histamine is released by basophils and mast cells, producing
allergic reactions associated with bronchial asthma, urticaria
and food allergy. Increased numbers of mast cells are associ-
ated with gastric mucosal damage induced by the use of NSA-
IDs (Rioux and Wallace, 1996). The use of NS seeds and its
active ingredients has a considerable effect on the histamine
mediated inﬂammatory and gastric diseases. A low concentra-
tion of nigellone effectively inhibits histamine release from
mast cells. Kanter et al. have shown that volatile oil therapy
of NS and more so its constituent TQ, signiﬁcantly reduced
mast cell number and the gastric ulcerated lesions in ethanol-
treated rats (Kanter et al., 2006). Myeloperoxidase activities
and histamine levels were found to be ampliﬁed in ethanol
treated rats, and NS or TQ treatment reversed this condition
suggesting that NS could partly shield gastric mucosal lining
from acute alcohol-induced damage. This gastroprotection
can be attributed to their antioxidant, antihistaminic and anti-
peroxidative effects. Stimulation process of gastric secretion
through histamine is suppressed with NS. This was supported
by the experiments with NS oil exhibiting an increase in
concentrations of mucin and glutathione transferase with a
simultaneous decline in the mucosal histamine concentrations
(El-Dakhakhny et al., 2000).
Low concentration of nigellone effectively inhibits the his-
tamine release from the mast cells, indicating an anti-asthmatic
role. TQ dimer isolated from NS’s volatile oil, ‘Nigellone’
suppressed symptoms when given orally to bronchial asthma
patients with effective results without any toxicity
(el-Dakhakhny, 1965). Administration of N. sativa oil to
patients with allergic problems, like allergic rhinitis, atopic
eczema, and bronchial asthma decreased the immunoglobulin
E, and eosinophil count (Kalus et al., 2003), indicating NS
oil effectiveness as adjuvant for treating allergic maladies.
The anti-allergic feature of NS seed constituents is due to their
anti-histaminic effects and this notion is duly supported by
in vitro studies too. In another study on guinea pig by Boskab-
ady and colleagues NS aqueous extract displays anti-histami-
nic and relaxant properties (Boskabady et al., 2004). The
inhibitory outcome of nigellone on histamine release from
rat peritoneal mast cells was shown to be mediated by dimin-
ishing intracellular calcium by the inhibition of protein kinase
C, a substance known to prompt histamine release as a result
of stimulation by various secretagogues and antigen sensitized
cells (Chakravarty, 1993; Gilani et al., 2001). Moreover, TQ
causes a concentration-dependent decrease in the tension of
the guinea pig isolated tracheal smooth muscle precontracted
by carbachol (Al-Majed et al., 2001). TQ totally eliminated
the pressor effects of histamine and serotonin, suggesting inhi-
bition effects mediated by lipoxygenase products of arachi-
donic acid production and possibly by non-selective blocking
of the serotonin and histamine receptors. In ethanol induced
gastric ulcer model a signiﬁcant increase in mucosal histamine
content was seen, but in rats pretreated with NS oil before
ulcer induction it caused a considerable decline in gastric
mucosal histamine content (El-Dakhakhny et al., 2000). Con-
trasting to the observed relaxant effect of TQ, a different study
compared stimulative effect of TQ with the NS volatile oil on
respiratory system of the urethane-anaesthetized guinea pig.
The intratracheal pressure and the respiratory rate increased
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dependent manner mediated by histamine release with direct
association of histaminergic mechanisms and indirect activa-
tion of muscarinic cholinergic methods (el Tahir et al., 1993).
Alternatively, TQ administration signiﬁcantly raises the intra-
tracheal pressure without changes in the respiratory pace.
Hence, it appears that special ingredients of NS oil possess
diverse impacts on histamine release. The NS active ingredient
nigellone acts as calcium channel blocker(s), explaining the
complimentary therapeutic usage of NS toward asthma, diar-
rhea and hypertension.
Although Marozzi and colleagues reported a TQ-induced his-
tamine enhancement in gastric ulcers induction, yet oral adminis-
tration of TQ prior to alcohol intake protected the animals
against alcohol-induced ulcers by approximately 38%. These
antioxidant mechanisms involved an increase in the superoxide
dismutase activity and reactive oxygen radical’s inhibition
(Marozzi et al., 1970; Tanaka et al., 2002). TQ thus exhibited a
slightly lesser potential effect than that of the whole volatile oil
(Kanter et al., 2003, 2005). TQ helps in retaining the NO content
thereby suppressing histamine release and reducing gastric acid
output (Marozzi et al., 1970). Peptic activity appears to be inhib-
ited by the suppression of histamine release, propelling a decrease
in the formation of pepsin from pepsinogens (Kanter et al., 2006).
This acid inﬂux is regulated by cGMP (Kato et al., 2009) and/or
release of somatostatin from cells (Arebi et al., 2002).3.6. Immunopharmacological and immunomodulatory functions
of N. sativa
The gastric mucosal cells are protected by the gastric mucosal
wall that prevents their exposure to exogenous and endogenous
irritants and toxins (Zayachkivska et al., 2005). Insults to this
layer precipitate in the development and progression of different
gastric disorders like gastric ulcers, cancers and gastritis. Differ-
ent ﬂavonoids and antioxidants of plant origin possess the poten-
tial to contribute protection to the gastric system and hasten up
the healing process. Anti-inﬂammatory properties of these com-
pounds render help by downregulation of the cytokine cascade
in the GI system (Alarcon de la Lastra et al., 1995). Suppression
of cytokines promotes the presence of beneﬁcial growth factors
which support tissue repair and aid healing. These growth factors
exhibit oxidant scavenging properties and also promote antioxi-
dant activities required for repair of oxidative stress insults to
the gastric mucosal lining (Liu et al., 2002; Pastrana-Bonilla
et al., 2003). In addition growth factors are bestowed with anti
carcinogenic and anti-nucleolytic, cytochrome P450 2F1 inhibi-
tory activities (Bagchi et al., 2002; Kyogoku et al., 1979). Like
many other herbs viz; Quercus, Swertia herb (Niiho et al.,
2006), Chinese herbal drug ‘‘Baishouwu’’ (Shan et al., 2006),
Phyllanthus niruri (Abdulla et al., 2010), several studies have
shown NS also as gastroprotective. A two gram dose was found
almost as effective as the traditional triple therapy in eradication
of H. pylori in earlier researches (Salem et al., 2010).
The oil and seed ingredients particularly TQ, display pro-
spective usage in traditional medicine and show valuable
immunomodulatory properties by boosting the natural killer
cell and T cell - mediated immune responses (Salem, 2005).
Also the active ingredients illustrated anti-tumor and antimi-
crobial properties toward different cancers and microbes.
The knowledge of potent immunomodulatory effects of TQcompels us to investigate TQ effects on the antigen presenting
cells, and on the Th-1 and Th-2 (helper T-cells) mediated
inﬂammatory immune diseases.
TQ exhibits gastroprotective mechanisms through neutro-
phil inﬁltration, acid secretion and proton pump inhibition.
It also enhances nitric oxide production and mucin secretion
(Magdy et al., 2012). Decreases in acid level mediated by TQ
are due to normalization of proton pump activity, thereby
inducing a decreased secretion of acid from the parietal cells.
20–50 lM concentration of TQ did not produce advanced gly-
cation end products implicated in chronic disorders and exhib-
ited toxic effects to platelet lactate dehydrogenase and plasma
thiols thereby increasing its potential in various food applica-
tions (Losso et al., 2011).
Cell apoptosis and cell growth inhibitory properties of TQ
have made this a potential molecule against various tumors. In
vitro experiments show that TQ assumes an essential role in the
sensitization, inhibition and augmentation of gastric tumor
cells to apoptosis induced by 5-ﬂourouracil (5-FU). This cell
inhibition depends on dosage of TQ as well as incubation time.
Western immunoblotting technique assessing protein expression
levels revealed a lowered expression of bcl-2, increased expres-
sion of bax protein, enhanced caspase-3 and caspase-9 activity
and efﬂux of cytochrome C into the cytosol. Therapeutic effects
show that incubation with TQ prior to adding 5-FU or addition
in conjunction could lead to the anti tumor effects of TQ. In vivo
antitumor effects on xenograft mice using the terminal deoxynu-
cleotidyl transferase-mediated dUTP-biotin nick end labeling
(TUNEL) assay showed that TQ in combination with 5-FU
showed a comparatively larger number of apoptotic bodies as
compared to the controls. Thus TQ triggers the apoptotic body
formation and inhibits cell viability (Lei et al., 2012).
3.7. Toxicity studies of N. sativa
NS has been associated relatively with very low toxicity. A his-
tory of NS usage as food and medicine reports rare adverse
effects following administration of the seeds within recom-
mended dosages. Contact dermatitis in a couple of cases fol-
lowing extensive use of high doses for longer periods of
topical use has been reported. As such no signiﬁcant harmful
side effects on any major organs and their functions has been
observed and reported in earlier studies. Studies conducted on
various aspects promote its safe usage in many inﬂammatory
conditions with low incidence of side effects. Doses as high
as 50–100 mg/kg have been shown to lower the GSH concen-
tration drastically; resulting in lowered GSH content and a
high mortality rate seen 24 h after reperfusion (El-Abhar
et al., 2003). Smaller doses are therefore advisable for treat-
ment purposes. Oral administration of the oil or seed formula-
tion does not have any adverse effect on liver or kidney
functions. Laboratory animal studies for acute chronic condi-
tions have reported that NS, its oil and TQ, are also safe when
given orally (Al-Ali et al., 2008; Badary et al., 1998; Mansour
et al., 2001).
4. Discussion and conclusion
NS is a very prized plant used in folk medicine, affording
protection against many ailments, one of them being gastro
protection. Plant origin bioactive substances and their
Gastro-protective role of Nigella 549functions help us in deciphering mechanisms of different GI
tract injury-related diseases and open up new vistas in
treatments. NS is a complex food additive with numerous
components, some of which are contributory toward its anti-
oxidant, anti-inﬂammatory, antimicrobial, cytoprotective and
immunotherapeutic potential. Mediators of inﬂammation
and oxidative stress seem to be targeted by this indigenous
bioactive factor rich seed. The drive of today’s health con-
scious man toward reducing risk of a particular disease has
become the prime approach toward identifying foods with
these enriched bioactive components and enhanced nutritional
value. Polyphenols, ﬂavonoids, bio-functional proteins and
lipids along with many phytochemicals exhibiting various
beneﬁts, make NS a very potent functional food additive for
gastro protection. Also its characteristic ability to exhibit the
various beneﬁts in aqueous, alcoholic as well as oil extracts
makes it the supplemental food of choice for future therapeu-
tics. Knowledge of their speciﬁc functions, mode of multiple
and synergetic action, cascade in the cell metabolism would
improve our utilization of functional food additives through
scientiﬁc evidence.
Ulcer indices appear to be considerably reduced following
pretreatment with NS exhibiting its preventing medicinal
effects (Kanter et al., 2005). Changes in composition of fatty
acids both in vivo and in vitro could alter membrane bound
receptors, enzyme action and various mechanisms of transport
involved. The antioxidant potential of NS is quite comparable
to Trolox, a recognized antioxidant standard compound ren-
dering it very beneﬁcial in antioxidant therapy.
Mechanisms by which TQ protects the gastric system may
be a combination of proton pump inhibition and retention
of anti-oxidative enzymes. Proton pump inhibition by TQ
appears to be a new property ascribed to it, which is instru-
mental in decreasing acid and pepsin production, and reducing
neutrophil inﬁltration. Also TQ reduces the oxidative insults to
the gastric system by increasing the enzyme antioxidant levels.
Combination therapy utilizing the properties and beneﬁts of
NS as well as available drugs can make future therapeutics
more acceptable to the common man (Magdy et al., 2012).
Components of NS or their derivatives could well be utilized
in different appropriate combinations for chemotherapy. NS
rich in PUFAs has shown in conjunction with other unique
chemical components, signiﬁcant gastro protective beneﬁts
over centuries. This entails its re-look and re-emergence in
leaps and bounds for the nutraceutical industry. NS can play
a novel and signiﬁcant role in the present restricted and skewed
pharmaceutical health approach. Invariably, NS seed, its oil
and extracts and its active ingredients, particularly TQ and
a-hederin, possess remarkable in vitro and in vivo healing activ-
ities against different types of cancers; unfortunately in theo-
retical applications not yet in practice.5. Future perspectives
Mechanism of NS action at the molecular level needs to be
explored to understand the cellular, anti-inﬂammatory and
immuno-modulatory effects. Damage limiting ability of NO
released by NSAID’s to the GI tract, makes NS a good candi-
date for combination therapy. Speciﬁc inhibitory effects with
the different active components would clarify the unknown
anti-inﬂammatory pathways by the way of modulation ofCOX1 or COX 2 enzymes. The role of 15-R-Lipoxin A4 and
its analogs in gastro protection could have immense therapeu-
tic value. Immuno-modulatory effects of shifts from the Th-1
pro-inﬂammatory type to the Th-2 anti-inﬂammatory type
could well be investigated. Cytoprotection creating innate cell
immunity and behavior of CD4 and CD8 T cells would pave
learning of speciﬁc and non-speciﬁc inhibitory effects. Mecha-
nism by which the gastric mucosa protects the GI tract against
exogenous damage using proton pump inhibitors and speciﬁc
cellular and molecular targets of the active components of
NS should be identiﬁed as different diseases exhibit differently
mediated pathways. Few studies show that platelets regulating
proteinase activated receptors which in turn aid in releasing the
protective growth factors for gastroprotection, may help in
deciphering the mechanism of action. Nutritional strategies
including food additives and combinations rich in omega-3 fats
should therefore be promoted for an enhanced production of
anti-inﬂammatory PG (Cleland et al., 1988). Drug designing
studies similar to capsaicin, may elucidate role of NS-sensitive
afferent nerves in gastro protection and promote ulcer healing.
This reverse pharmacological approach by scientiﬁcally reval-
idating the ancient and neglected medical experience can
reshape our outlook toward this invaluable but neglected her-
bal medicine. We hope this review article would offer a source
of information to researchers in the ﬁeld of gastric cancer and
NS to plan and conduct their experiments as future studies on
this subject are warranted.
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